MSH|^~\&|LAB|RMH|||201911151430||ORU^R01|4106566|D|2.3|||AL|NE
PID|1||RM00003515|RM3122|LABTEST^XRMCARDIAC^TWO||19451118|F||||||||||RM000409/18|9875418556
OBR|1|35220^LAB|00027057^1511:C00007R^LAB^151119:C7^35220|220.5080^HFE CD^Hemochromatosis-Conf Diagnosis^^^XXX-1182||201911151430|201911151430|||||||201911151430||||||||||LAB|I||||
OBR|2|35220^LAB|00027057^1511:C00007R^LAB^151119:C7^35220|520.4200^IRON^Iron Studies Profile^^^50190-8||201911151430|201911151430|||||||201911151430||||||||||LAB|F||||
OBX|1|ST|520.4300^FE^Iron^^14798-3^14798-3|1|25^^Y|umol/L|9-30|N||A^S|F|||201911151430
OBX|2|ST|520.4500^TIBC^Total Iron Binding Capacity^^14800-7^14800-7|1|30^^Y|umol/L|45-70|L||A^S|F|||201911151430
OBX|3|ST|520.4600^TRFSAT^Transferrin Saturation^^6796-7^14801-5|1|0.83^^Y||0.15-0.55|H||A^S|F|||201911151430
NTE|1||Markedly elevated transferrin saturation.  Follow up and
NTE|2||management as per BCMA/MSP Iron Overload protocol.

MSH|^~\&|LAB|RMH|||201911151431||ORU^R01|4106567|D|2.3|||AL|NE
PID|1||RM00003515|RM3122|LABTEST^XRMCARDIAC^TWO||19451118|F||||||||||RM000409/18|9875418556
OBR|1|35220^LAB|00027057^1511:C00007R^LAB^151119:C7^35220|220.5080^HFE CD^Hemochromatosis-Conf Diagnosis^^^XXX-1182||201911151430|201911151430|||||||201911151430||||||||||LAB|F||||
OBX|1|ST|520.4700^FER^Ferritin^^2276-4^2276-4|1|306^^Y|ug/L|15-160|H||A^S|F|||201911151431
OBR|2|35220^LAB|00027057^1511:C00007R^LAB^151119:C7^35220|520.4200^IRON^Iron Studies Profile^^^50190-8||201911151430|201911151430|||||||201911151430||||||||||LAB|F||||
OBX|1|ST|520.4300^FE^Iron^^14798-3^14798-3|1|25^^Y|umol/L|9-30|N||A^S|F|||201911151430
OBX|2|ST|520.4500^TIBC^Total Iron Binding Capacity^^14800-7^14800-7|1|30^^Y|umol/L|45-70|L||A^S|F|||201911151430
OBX|3|ST|520.4600^TRFSAT^Transferrin Saturation^^6796-7^14801-5|1|0.83^^Y||0.15-0.55|H||A^S|C|||201911151431
NTE|1||Hyperferritinemia and elevated transferrin saturation index:
NTE|2||Patient meets criteria for HFE genetic testing as specified
NTE|3||in the current BC Guidelines.
NTE|4||   ****   CORRECTED RESULT  ****
NTE|5||   ---  15/11/19 1431 ---
NTE|6||  TRFSAT previously reported as: 0.83  H
NTE|7||
NTE|8||
NTE|9||Markedly elevated transferrin saturation.  Follow up and
NTE|10||management as per BCMA/MSP Iron Overload protocol.
OBR|3|35220^LAB|00027057^1511:C00007R^LAB^151119:C7^35220|520.4720^HFE HH^Hemochromatosis^^^XXX-1182||201911151430|201911151430|||||||201911151430||||||||||LAB|I||||